General Interest

Not Interested
Bookmark
Report This Job

profile Job Location:

Cambridge, MA - USA

profile Monthly Salary: Not Disclosed
Posted on: 3 days ago
Vacancies: 1 Vacancy

Job Summary

Alkeus Pharmaceuticals Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge Mass. Alkeus was founded in 2010 and since that time has been developing its lead compound gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD) a leading cause of blindness in the U.S.

We are looking for enthusiastic professionals who want to be at the forefront of our mission and make a significant impact on the growth and direction of Alkeus Pharmaceuticals.

We invite you to apply and submit your resume for general consideration.

#LI-DNI

Alkeus Pharmaceuticals Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.

Alkeus Pharmaceuticals Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge Mass. Alkeus was founded in 2010 and since that time has been developing its lead compound gildeuretinol ac...
View more view more

Key Skills

  • General Ledger Reconciliation
  • Taleo
  • GAAP
  • Journal Entries
  • QuickBooks
  • General Ledger Accounting
  • Accounting
  • Microsoft Dynamics Navision
  • Account Reconciliation
  • Accrual Accounting
  • Microsoft Dynamics GP
  • Accounts Payable

About Company

Company Logo

SAGA was a 24-month, double-masked, randomized, placebo-controlled trial to investigate the safety, pharmacokinetics, tolerability and efficacy in patients with geographic atrophy secondary to AMD.

View Profile View Profile